JP2009529974A - 活性補助剤が結合した、安定化殺菌コラーゲン足場 - Google Patents

活性補助剤が結合した、安定化殺菌コラーゲン足場 Download PDF

Info

Publication number
JP2009529974A
JP2009529974A JP2009500520A JP2009500520A JP2009529974A JP 2009529974 A JP2009529974 A JP 2009529974A JP 2009500520 A JP2009500520 A JP 2009500520A JP 2009500520 A JP2009500520 A JP 2009500520A JP 2009529974 A JP2009529974 A JP 2009529974A
Authority
JP
Japan
Prior art keywords
tissue
growth factor
bone
natural
biological tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009500520A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009529974A5 (enExample
Inventor
ナタラジ，チャンドラセカラン
リッター，グレッグ
サンダー，トーマス
Original Assignee
ペガサス・バイオロジックス・インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ペガサス・バイオロジックス・インコーポレーテッド filed Critical ペガサス・バイオロジックス・インコーポレーテッド
Publication of JP2009529974A publication Critical patent/JP2009529974A/ja
Publication of JP2009529974A5 publication Critical patent/JP2009529974A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/34—Muscles; Smooth muscle cells; Heart; Cardiac stem cells; Myoblasts; Myocytes; Cardiomyocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/005—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters containing a biologically active substance, e.g. a medicament or a biocide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/06—At least partially resorbable materials
    • A61L17/08—At least partially resorbable materials of animal origin, e.g. catgut, collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/0005—Use of materials characterised by their function or physical properties
    • A61L33/0011—Anticoagulant, e.g. heparin, platelet aggregation inhibitor, fibrinolytic agent, other than enzymes, attached to the substrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L33/00—Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment
    • A61L33/18—Use of ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/28—Bones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/30756—Cartilage endoprostheses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/28—Bones
    • A61F2002/2817—Bone stimulation by chemical reactions or by osteogenic or biological products for enhancing ossification, e.g. by bone morphogenetic or morphogenic proteins [BMP] or by transforming growth factors [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30667—Features concerning an interaction with the environment or a particular use of the prosthesis
    • A61F2002/30677—Means for introducing or releasing pharmaceutical products, e.g. antibiotics, into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/30—Joints
    • A61F2/30756—Cartilage endoprostheses
    • A61F2002/30766—Scaffolds for cartilage ingrowth and regeneration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005—The prosthesis being constructed from a particular material
    • A61F2310/00359—Bone or bony tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
    • A61F2310/00005—The prosthesis being constructed from a particular material
    • A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Surgery (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Vascular Medicine (AREA)
  • Materials Engineering (AREA)
  • Botany (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
JP2009500520A 2006-03-17 2007-03-16 活性補助剤が結合した、安定化殺菌コラーゲン足場 Pending JP2009529974A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US74354206P 2006-03-17 2006-03-17
US11/686,859 US20070218038A1 (en) 2006-03-17 2007-03-15 Stabilized, sterilized collagen scaffolds with active adjuncts attached
PCT/US2007/006716 WO2007109180A2 (en) 2006-03-17 2007-03-16 Stabilized, sterilized collagen scaffolds with active adjuncts attached

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012257084A Division JP2013063283A (ja) 2006-03-17 2012-11-26 活性補助剤が結合した、安定化殺菌コラーゲン足場

Publications (2)

Publication Number Publication Date
JP2009529974A true JP2009529974A (ja) 2009-08-27
JP2009529974A5 JP2009529974A5 (enExample) 2013-01-24

Family

ID=38518079

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2009500520A Pending JP2009529974A (ja) 2006-03-17 2007-03-16 活性補助剤が結合した、安定化殺菌コラーゲン足場
JP2012257084A Withdrawn JP2013063283A (ja) 2006-03-17 2012-11-26 活性補助剤が結合した、安定化殺菌コラーゲン足場
JP2015232066A Active JP6298437B2 (ja) 2006-03-17 2015-11-27 活性補助剤が結合した、安定化殺菌コラーゲン足場

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2012257084A Withdrawn JP2013063283A (ja) 2006-03-17 2012-11-26 活性補助剤が結合した、安定化殺菌コラーゲン足場
JP2015232066A Active JP6298437B2 (ja) 2006-03-17 2015-11-27 活性補助剤が結合した、安定化殺菌コラーゲン足場

Country Status (7)

Country Link
US (3) US20070218038A1 (enExample)
EP (2) EP2001521B1 (enExample)
JP (3) JP2009529974A (enExample)
AU (1) AU2007227462B2 (enExample)
CA (1) CA2646067C (enExample)
ES (2) ES3042186T3 (enExample)
WO (1) WO2007109180A2 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013513428A (ja) * 2009-12-13 2013-04-22 アミット プラカシュ ゴヴィル 生体活性のある移植片およびコンポジット
JP2015526148A (ja) * 2012-07-18 2015-09-10 ヴィデレゲン リミテッドＶｉｄｅｒｅｇｅｎ Ｌｉｍｉｔｅｄ インプラント及びインプラントの製法

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2091569A4 (en) * 2006-10-31 2011-09-14 Univ Rochester TARGETED DELIVERY OF THERAPEUTIC AGENTS USING LYOPHILIZED MATRICES
US20090036656A1 (en) * 2007-07-31 2009-02-05 Body Organ Biomedical Corp. Method for preparing a biomaterial
US20110212524A1 (en) * 2006-12-04 2011-09-01 Body Organ Biomedical Corporation Biomaterial and preparation method thereof
AU2009217269B2 (en) * 2008-02-21 2014-10-02 Dermacare Neuroscience Institute Cosmetic and dermatological formulations of MNTF peptides
WO2009105760A2 (en) * 2008-02-22 2009-08-27 Musculoskeletal Transplant Foundation Biologic matrices comprising anti-infective, methods and compositions related thereto
AU2009257400B2 (en) * 2008-06-11 2014-05-01 The Children's Mercy Hospital Solutions for tissue engineering and methods of use
DK2550027T4 (da) * 2010-03-22 2019-05-13 Allergan Inc Tværbundne polysaccharid- og protein-polysaccharid-hydrogeler til blødvævsforøgelse
US9155607B2 (en) * 2011-11-16 2015-10-13 Purdue Research Foundation Compositions and methods for repair or regeneration of soft tissue
EP2787923B1 (en) 2011-12-09 2018-10-31 The Board of Trustees of The Leland Stanford Junior University Decellularized composite tissue bioscaffolds for musculoskeletal tissue interface reconstruction and methods of production
KR102312720B1 (ko) * 2013-03-15 2021-10-13 알로소스 연조직 회복 및 재생을 위한 세포 재배치된 콜라겐 매트릭스
EP2983718A4 (en) * 2013-04-11 2016-12-07 Univ Of Vermont And State Agricultural College Decellularization and recellularization of whole organs
US9238090B1 (en) 2014-12-24 2016-01-19 Fettech, Llc Tissue-based compositions
CA3009153A1 (en) 2015-01-30 2016-08-04 The University Of North Carolina At Chapel Hill Methods to generate gastrointestinal epithelial tissue constructs
CN107750274A (zh) 2015-06-08 2018-03-02 康宁股份有限公司 用于水凝胶微载体的干燥制剂
CN108697417B (zh) * 2015-08-18 2022-07-05 科医公司 抗微生物伤口闭合材料，包括抗微生物缝合线，和使用所述材料闭合伤口的方法
KR101710615B1 (ko) * 2016-09-07 2017-02-27 주식회사 파마리서치프로덕트 생착률을 증가시킨 이식용 진피층 및 이의 제조 방법
WO2019194894A1 (en) * 2018-04-06 2019-10-10 The Regents Of The University Of California Nanoparticulate mineralized collagen glycosaminoglycan scaffold with an anti-resorption factor
CA3093581A1 (en) 2018-05-15 2019-11-21 The University Of North Carolina At Chapel Hill Devices, systems and apparatuses for generating self-sustaining hypoxic conditions and gaseous and non-gaseous chemical gradients for in vitro cell culture
US20230098968A1 (en) 2018-05-25 2023-03-30 The University Of North Carolina At Chapel Hill Formation of arrays of planar intestinal crypts possessing a stem/proliferative cell compartment and differentiated cell zone
CN109833118B (zh) * 2018-09-29 2020-07-07 四川大学 一种采用交联处理提高生物瓣膜稳定性的方法
JP2022511375A (ja) 2018-11-16 2022-01-31 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル インビトロ細胞培養粘液系
US11692161B2 (en) 2019-02-05 2023-07-04 Corning Incorporated Packed-bed bioreactor systems and methods of using the same
US11118151B2 (en) 2019-11-05 2021-09-14 Corning Incorporated Fixed bed bioreactor and methods of using the same
CN114028613A (zh) * 2021-10-21 2022-02-11 潍坊医学院 一种功能性骨修复复合支架、制备方法及应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59177042A (ja) * 1983-03-29 1984-10-06 マ−セル・イ−・ニムニ 生物学的補綴具のための皮膜及びその製造方法
JP2001120654A (ja) * 1999-10-22 2001-05-08 Korea Advanced Inst Of Sci Technol ヘパリン処理された抗石灰化性生体組織移植物及びこの製造方法
JP2001512333A (ja) * 1997-02-10 2001-08-21 バイオメディカル デザイン インコーポレイテッド 滅菌法
JP2001520539A (ja) * 1997-04-16 2001-10-30 バクスター インターナショナル インコーポレイテッド 架橋された生体組織に活性なようにヘパリンを結合させるための方法
JP2005523733A (ja) * 2001-07-16 2005-08-11 デピュイ・プロダクツ・インコーポレイテッド 多孔質配給支持骨格材料および方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ177159A (en) 1974-04-20 1978-03-06 Beecham Group Ltd Clavulanic acid, salts, esters and preparation thereof from streptomyces clavuligerus: pharmaceutical compositions
US4529720A (en) 1974-04-20 1985-07-16 Beecham Group, P.L.C. Antibiotic from Streptomyces clavulicerus
US4378224A (en) 1980-09-19 1983-03-29 Nimni Marcel E Coating for bioprosthetic device and method of making same
EP0121008A3 (en) * 1983-03-29 1985-03-27 Marcel E. Nimni Coating for bioprosthetic device and method of making same
US4448718A (en) * 1983-09-13 1984-05-15 Massachusetts Institute Of Technology Method for the preparation of collagen-glycosaminoglycan composite materials
BR9007643A (pt) 1989-09-15 1992-08-18 Chiron Ophthalmics Inc Metodo para se conseguir a epitelizacao de lentes sinteticas
US5308641A (en) 1993-01-19 1994-05-03 Medtronic, Inc. Biocompatibility of solid surfaces
US5447536A (en) * 1994-02-17 1995-09-05 Biomedical Design, Inc. Method for fixation of biological tissue
JP3708567B2 (ja) * 1994-07-20 2005-10-19 日清紡績株式会社 生物学的に活性な物質を固定するための方法
US5733337A (en) 1995-04-07 1998-03-31 Organogenesis, Inc. Tissue repair fabric
US6048964A (en) * 1995-12-12 2000-04-11 Stryker Corporation Compositions and therapeutic methods using morphogenic proteins and stimulatory factors
US6506339B1 (en) * 1997-02-10 2003-01-14 Biomedical Design, Inc. Method of sterilization
US6117979A (en) * 1997-08-18 2000-09-12 Medtronic, Inc. Process for making a bioprosthetic device and implants produced therefrom
DE69900864T2 (de) * 1998-03-23 2002-09-05 Bio-Vascular, Inc. Implantate und verfahren zu deren herstellung
US6521179B1 (en) 1999-08-11 2003-02-18 Biomedical Design, Inc. Sterilization
US6623963B1 (en) * 1999-12-20 2003-09-23 Verigen Ag Cellular matrix
CA2401869A1 (en) 2000-03-03 2001-09-07 Syntacoll Ag Agent for the treatment of wounds
AU2000238098A1 (en) 2000-03-09 2001-09-17 Syntacoll Ag Novel natural polymer-based material with improved properties for use in human and veterinary medicine and the method of manufacturing such
EP1263485B1 (en) 2000-03-09 2005-03-02 Syntacoll AG Multilayer collagen matrix for tissue reconstruction
US6444222B1 (en) * 2001-05-08 2002-09-03 Verigen Transplantation Services International Ag Reinforced matrices
WO2003007786A2 (en) * 2001-07-16 2003-01-30 Depuy Products, Inc. Porous delivery scaffold and method
WO2003032735A1 (en) * 2001-10-18 2003-04-24 Lifecell Corporation Remodeling of tissues and organs
EP1476583B1 (en) * 2002-01-25 2013-08-28 Biomedical Design, Inc. Calcification-resistant fixation
US6982298B2 (en) * 2003-01-10 2006-01-03 The Cleveland Clinic Foundation Hydroxyphenyl cross-linked macromolecular network and applications thereof
WO2005049105A2 (en) 2003-11-10 2005-06-02 Angiotech International Ag Medical implants and anti-scarring agents
JPWO2005063316A1 (ja) * 2003-12-26 2007-12-20 公立大学法人大阪府立大学 移植可能な生体材料およびその作成方法
EP1796693A2 (en) * 2004-08-26 2007-06-20 Chandrashekhar P. Pathak Implantable tissue compositions and method

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59177042A (ja) * 1983-03-29 1984-10-06 マ−セル・イ−・ニムニ 生物学的補綴具のための皮膜及びその製造方法
JP2001512333A (ja) * 1997-02-10 2001-08-21 バイオメディカル デザイン インコーポレイテッド 滅菌法
JP2001520539A (ja) * 1997-04-16 2001-10-30 バクスター インターナショナル インコーポレイテッド 架橋された生体組織に活性なようにヘパリンを結合させるための方法
JP2001120654A (ja) * 1999-10-22 2001-05-08 Korea Advanced Inst Of Sci Technol ヘパリン処理された抗石灰化性生体組織移植物及びこの製造方法
JP2005523733A (ja) * 2001-07-16 2005-08-11 デピュイ・プロダクツ・インコーポレイテッド 多孔質配給支持骨格材料および方法

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013513428A (ja) * 2009-12-13 2013-04-22 アミット プラカシュ ゴヴィル 生体活性のある移植片およびコンポジット
JP2015526148A (ja) * 2012-07-18 2015-09-10 ヴィデレゲン リミテッドＶｉｄｅｒｅｇｅｎ Ｌｉｍｉｔｅｄ インプラント及びインプラントの製法

Also Published As

Publication number Publication date
ES3042186T3 (en) 2025-11-19
EP3545963B1 (en) 2025-06-25
WO2007109180A2 (en) 2007-09-27
JP2013063283A (ja) 2013-04-11
AU2007227462A1 (en) 2007-09-27
JP6298437B2 (ja) 2018-03-20
US9694037B2 (en) 2017-07-04
CA2646067C (en) 2015-11-03
US20100266559A1 (en) 2010-10-21
US9272004B2 (en) 2016-03-01
EP2001521A4 (en) 2012-06-20
EP2001521B1 (en) 2019-07-31
AU2007227462B2 (en) 2012-08-02
ES2751911T3 (es) 2020-04-02
US20070218038A1 (en) 2007-09-20
CA2646067A1 (en) 2007-09-27
JP2016064141A (ja) 2016-04-28
US20090196898A1 (en) 2009-08-06
WO2007109180A3 (en) 2008-10-30
EP2001521A2 (en) 2008-12-17
EP3545963A1 (en) 2019-10-02

Similar Documents

Publication Publication Date Title
JP6298437B2 (ja) 活性補助剤が結合した、安定化殺菌コラーゲン足場
JP2009529974A5 (enExample)
US8546529B2 (en) Injectable bone regeneration gel containing bone formation enhancing peptide
US8328876B2 (en) Bone matrix compositions and methods
US8920827B2 (en) Keratin bioceramic compositions
US20090291114A1 (en) Osteogenic composition comprising a growth factor/amphiphilic polymer complex, a soluble cation salt and an organic support
US20140079753A1 (en) Bmp binding peptides
KR20070009527A (ko) 정형외과 인플란트의 항균성 히알루론산 코팅
JP6518198B2 (ja) 薬物放出のための化合物及び組成物
Policastro et al. Osteogenic growth peptide and its use as a bio‐conjugate in regenerative medicine applications
WO2012158169A1 (en) Methods and compositions for tissue repair
White et al. Spatiotemporal control strategies for bone formation through tissue engineering and regenerative medicine approaches
US9981010B2 (en) Methods and compositions for bone formation
Urist Enzymes in bone morphogenesis: endogenous enzymic degradation of the morphogenetic property in bone in solutions buffered by ethylenediaminetetraacetic acid (EDTA)
US8137664B2 (en) Method and kit for repairing a defect in bone
WO2011143187A2 (en) Lactoferrin -based biomaterials for tissue regeneration and drug delivery
AU2011251991A1 (en) Lactoferrin -based biomaterials for tissue regeneration and drug delivery
White Microscale patterning of osteogenic response and mineralization on PEGDA hydrogels
Osińska et al. Immobilizacja amikacyny na różnych typach protez naczyniowych

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20100309

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20100316

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100316

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20100309

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110613

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120905

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20121126

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20121126

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130305

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130517

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20130517

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20130610

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20130705

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140526

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140530